About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical firm at the forefront of transforming treatments for central nervous system (CNS) disorders. We specialize in delivering groundbreaking scientific advancements by addressing critical gaps in patient care. Our innovative product line features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, as well as migraine relief. We are also engaged in multiple late-stage development programs aimed at tackling a wide spectrum of serious neurological and psychiatric conditions that affect over 150 million individuals in the United States. Our mission is to solve some of the most pressing challenges in brain health, empowering patients and their families to thrive.

